CAS 124447-81-0

Amylin (mouse, rat)

CAS : 124447-81-0

Rat amylin (rIAPP) lacks the fibril-forming capacity of human amylin (hIAPP). As a consequence, toxic effects have been reported for the human but not for the rat peptide amide.

Formule : C₁₆₇H₂₇₂N₅₂O₅₃S₂

Degré de pureté : 96.1%

Couleur et forme : White

Masse moléculaire : 3920.45

Ref: 01-4030201

Amylin receptor

CAS : 124447-81-0

Formule : C₁₆₇H₂₇₂N₅₂O₅₃S₂

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 3920.3932

Ref: IN-DA000M1D

Amylin, amide, rat

CAS : 124447-81-0

Amylin: peptide, 50% similar to CGRP, found with somatostatin in stomach cells, reduces acid secretion in mice.

Formule : C₁₆₇H₂₇₂N₅₂O₅₃S₂

Degré de pureté : 99.92%

Couleur et forme : Solid

Masse moléculaire : 3920.44

Ref: TM-TP1232

Amylin (Rat)

Produit contrôlé

CAS : 124447-81-0

Amylin is a peptide that belongs to the group of activators. It has been shown to be an inhibitor of ion channels, and has also been demonstrated to activate cell signaling pathways. Amylin can be used as a research tool for studying protein interactions, receptor ligands, and pharmacology. Amylin can be used in antibody production or as a high-purity reagent for life science or cell biology applications.

Formule : C₁₆₇H₂₇₂N₅₂O₅₃S₂

Degré de pureté : Min. 95%

Masse moléculaire : 3,920.4 g/mol

Ref: 3D-PAM-4220-V

Amylin (mouse, rat) trifluoroacetate

CAS : 124447-81-0

Amylin (mouse, rat) trifluoroacetate is a synthetic peptide, which is a derivative of the islet amyloid polypeptide (IAPP) found in rodent species. It is sourced from the pancreatic beta cells of mice and rats, where it is co-secreted with insulin. The mode of action involves regulation of glucose metabolism through its effects on gastric emptying, glucagon secretion, and satiety. These actions are crucial in managing postprandial blood glucose levels and provide insights into the pathophysiology of diabetes.Amylin (mouse, rat) trifluoroacetate is primarily used in research applications to study the mechanisms of amylin aggregation and its implications in type 2 diabetes. It also serves as a model for understanding the differences in amyloid fibril formation between human and rodent amylin, making it invaluable for the development of therapeutic strategies aimed at mitigating amyloid-related cellular toxicity. Researchers utilize this peptide to explore the potential compensatory roles of amylin analogs in diabetic models, advancing our understanding of diabetes progression and treatment options.

Formule : C₁₆₇H₂₇₂N₅₂O₅₃S₂•(C₂HF₃O₂)x

Degré de pureté : Min. 95%

Masse moléculaire : 3,920.4 g/mol

Ref: 3D-FA110436